Abstract
The increasing number of transplant centers has resulted in providing lung transplantation as a therapeutic option for many patients with end-stage pulmonary diseases. However, despite improvements in immunosuppression, surgical techniques, and diagnostic accuracy, post-transplant complications remain problematic. One of the key elements to patient survival is the prompt and appropriate intervention of allograft dysfunction[1]. While there are a number of ways to monitor the recipient, tissue examination still remains the mainstay in assessing allograft alterations[2]’[5]. Perhaps it is important to distinguish between rejection and non-rejection processes such as infection, since treatment is often opposite. Graft syndromes typically occur in their particular context, and it is the understanding of the adaptation of the lung allograft to the host environment which is critical in arriving at the correct diagnosis. The intent of this chapter is to review the histopathology and pathophysiology of lung allograft rejection and other non-rejection processes which may also contribute to graft dysfunction. The efficacy of types of biopsies in specific situations will also be discussed.
Chapter PDF
Similar content being viewed by others
Keywords
- Transplant Recipient
- Lung Transplant
- Chronic Rejection
- Bronchiolitis Obliterans Syndrome
- Diffuse Alveolar Damage
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.
References
Griffith BP, Hardesty RL, Trento A et al. Heart-lung transplantation: lessons learned and future hopes. Ann Thorac Surg. 1987;43:6–16.
Higenbottam T, Stewart S, Penketh A, Wallwork J. Transbronchial lung biopsy for the diagnosis of rejection in heart-lung transplant patients. Transplantation. 1988;46:532–9.
Marchevsky A, Hartman G, Walls A et al. Lung transplantation: the pathologic diagnosis of pulmonary complications. Mod Pathol. 1991;4:133–8.
Sibley RK, Berry GJ, Tazelaar HD et al. The role of transbronchial biopsies in the management of lung transplant recipients. J Heart Lung Transplant. 1993;12:308–24.
Trulock EP, Ettinger NA, Brunt EA et al. The role of transbronchial lung biopsy in the treatment of lung transplant recipients. Chest. 1992;102:1049–54.
Prop JM, Ehric MG, Crapo JD, Nieuwenhuis P, Wildevuur CRH. Reimplantation response in isografted rat lungs. J Thorac Cardiovasc Surg. 1984;87:702–11.
Jamieson S, Baldwin J, Stinson E et al. Clinical heart-lung transplantation. Transplantation. 1984;37:81.
Yousem SA, Burke CM, Billingham ME. Pathologic pulmonary alterations in longterm human heart-lung transplantation. Hum Pathol. 1985;16:911–23.
Zenati M, Yousem SA, Dowling RD, Stein KL, Bartley PG. Primary graft failure following pulmonary transplantation. Transplantation. 1990;50:165–7.
Yousem SA, Duncan SR, Griffith BP. Interstitial and airspace granulation tissue reactions in lung transplant recipients. Am J Surg Pathol. 1992;16:877–84.
Ohori NP, Iacono AT, Grgurich WE, Yousem SA. Significance of acute bronchitis/bronchiolitis in the lung transplant recipient. Am J Surg Pathol. 1994;18:1192–204.
Abernathy EC, Hruban RH, Baumgartner WA, Reitz B, Hutchins GM. The two forms of bronchiolitis obliterans in heart-lung transplant recipients. Hum Pathol. 1991;22:1102–10.
Hardy JD, Webb WR, Dalton ML Jr et al. Lung homotransplantation in man. J Am Med Assoc. 1963;186:1065–74.
Deffebach ME, Charan NB, Lakshminarayan S, Butler J. The bronchial circulation: small, but a vital attribute of the lung. Am Rev Respir Dis. 1987;135:463–8.
Morgan E, Lima O, Goldberg M, Ferdman A, Luk SK, Cooper JD. Successful revascularization of totally ischemic bronchial autografts with omental pedicle flaps in dogs. J Thorac Cardiovasc Surg. 1982;84:204–10.
Novick RJ, Ahmad D, Menkis AH et al. The importance of acquired diffuse bronchomalacia in heart-lung transplant recipients with obliterative bronchiolitis. J Thorac Cardiovasc Surg. 1991;101:643–8.
Yousem SA, Dauber JH, Griffith BP. Bronchial cartilage alterations in lung transplantation. Chest. 1990;98:1121–4.
Frost AE, Keller CA, Cagle PT, the Multi-Organ Transplant Group. Severe ischemic injury to the proximal airway following lung transplantation. Chest. 1993;103:1899–901.
Rosendale BE, Keenan RJ, Duncan SR et al. Donor cerebral emboli as a cause of acute graft dysfunction in lung transplantation. J Heart Lung Transplant. 1992;11:72–6.
Tavakoli R, Devaux TY, Nonnenmacher L, Louvel A, Houssin D. Xenogeneic hyperacute rejection in the lung in rats. Chirurgie. 1990;116:684–9.
Demetris AJ, Jaffe R, Tzakis A et al. Antibody-mediated rejection of human orthotopic liver allografts. Am J Pathol. 1988;132:489–502.
Hruban RH, Beschorner WE, Baumgartner WA et al. Depletion of bronchus-associated lymphoid tissue associated with lung allograft rejection. Am J Pathol. 1988;132:6–11.
Prop J, Wildevuur CRH, Nieuwenhuis P. Lung allograft rejection in the rat: specific immunologie properties of lung grafts. Transplantation. 1985;40:126–31.
Prop J, Wildevuur CRH, Nieuwenhuis P. Lung allograft rejection in the rat: corresponding morphologic rejection phases in various rat strain combinations. Transplantation. 1985;40:132–6.
Glanville AR, Tazelaar HD, Theodore J et al. The distribution of MHC class I and II antigens on bronchial epithelium. Am Rev Respir Dis. 1989;139:330–4.
Yousem SA, Curley JM, Dauber J et al. HLA-class II antigen expression in human heart-lung allografts. Transplantation. 1990;49:991–5.
Hruban RH, Beschorner WE, Baumgartner WA et al. Evidence that the expression of class II MHC antigens is not diagnostic of lung allograft rejection. Transplantation. 1989;48:529–30.
Glanville AR, Tazelaar HD, Theodore J et al. The distribution of MHC class I and II antigens on bronchial epithelium. Am Rev Respir Dis. 1989;139:330–4.
De Blic J, Peuchmaur M, Carnot F et al. Rejection in lung transplantation — an immunohistochemical study of transbronchial biopsies. Transplantation. 1992;54:639–44.
Yousem SA, Sonmez-Alpan E. Use of a biotinylated DNA probe specific for the human Y chromosome in the evaluation of the allograft lung. Chest. 1991;99:275–9.
Kubit V, Somnez-Alpan E, Zeevi A et al. Mixed allogeneic chimerism in lung allograft recipients. Hum Pathol. 1994;25:408–12.
Yamamoto R, Kinoshita H, Kinoshita Y, Mizoguchi S, Inoue K, Kishi A. Immunohistochemical aspects of acute rejection of the allografted rat lung. Transplantation. 1990;49:631–2.
Yousem SA, Martin T. Can immunohistochemical analysis of transbronchial biopsy specimens predict responder status in early acute rejection of lung allografts? Hum Pathol. 1994;25:525–9.
Hasegawa S, Ockner DM, Ruler JH et al. Expression of class II major histocompatibility complex antigens (HLA-DR) and lymphocyte subset immunotyping in chronic pulmonary transplant rejection. Arch Pathol Lab Med. 1995;119:432–9.
Veith FJ, Sinha SBP, Daughtery JC et al. Nature and evolution of lung allograft rejection with und without immunosuppression. J Thorac Cardiovasc Surg. 1972;63:509.
Veith FJ, Koerner Sk, Siegelman SS et al. Diagnosis and reversal of rejection in experimental and clinical lung allografts. Ann Thorac Surg. 1973;16:172.
Yousem SA, Duncan SR, Ohori NP, Sonmez-Alpan E. Architectural remodeling of lung allografts in acute and chronic rejection. Arch Pathol Lab Med. 1992;116:1175–80.
Yousem SA, Berry GJ, Brunt EM et al. A working formulation of the standardization of nomenclature in the diagnosis of heart and lung rejection: lung rejection study group. J Heart Lung Transplant. 1990;9:593–601.
Veith F, Sinha S, Blumcke S et al. Nature and evolution of lung allograll rejection with and without immunosuppression. J Thorac Cardiovasc Surg. 1972;63:509.
Halasz NA, Catanzaro A, Trummer MJ et al. Transplantation of the lung: correlation of physiologic, immunologic, and histologic findings. J Thorac Cardiovasc Surg. 1973;66:581–7.
Yousem SA. Lymphocytic bronchitis/bronchiolitis in lung allograft recipients. Am J Surg Pathol. 1993;17:491–6.
Yousem SA, Paradis IL, Dauber JA et al. Large airway inflammation in heart-lung transplant recipients-its significance and prognostic implications. Transplantation. 1990;49:654–6.
Tazelaar HD. Perivascular inflammation in pulmonary infections: implications for the diagnosis of lung rejection. J Heart Lung Transplant. 1991;10:437–41.
Nakhleh RE, Bolman RM, Henke CA, Hertz MI. Lung transplant pathology: a comparative study of pulmonary acute rejection and cytomegalovirus infection. Am J Surg Pathol. 1991;15:1197–201.
Tazelaar HD, Nilsson FN, Rinaldi M et al. The sensitivity of transbronchial biopsy for the diagnosis of acute lung rejection. J Thorac Cardiovasc Surg. 1993;105:674–8.
Starnes VA, Theodore J, Oyer PE et al. Evaluation of heart-lung transplant recipients with prospective serial transbronchial biopsies and pulmonary function studies. J Thorac Cardiovasc Surg. 1989;98:683–95.
Starnes VA, Theodore J, Oyer PE et al. Pulmonary infiltrates after heart — lung transplantation: evaluation by serial transbronchial biopsies. J Thorac Cardiovasc Surg. 1989;98:945–50.
Yousem SA, Paradis IL, Dauber JH et al. Pulmonary arteriosclerosis in long-term human heart-lung transplant recipients. Transplantation. 1989;47:564–9.
Clelland C, Higenbottam T, Otulana B et al. Histologic prognostic indicators for the lung allografts of heart lung transplants. J Heart Transplant. 1990;9:177–86.
Bando K, Paradis IL, Konishi H et al. Obliterative bronchiolitis after lung and heart-lung transplantation: an analysis of risk factors and management. J Thorac Cardiovasc Surg. (In press).
Holland V, Cagle PT, Windsor NT, Noon GP, Greenberg SD, Lawrence EC. Lymphocyte subset populations in bronchiolitis obliterans after heart-lung transplantation. Transplantation. 1990;50:955–9.
Taylor PM, Rose ML, Yacoub MH. Expression of MHC antigen in normal human lung and transplanted lungs with obliterative bronchiolits. Transplantation. 1989;48:506–10.
Tazelaar HD, Yousem SA. The pathology of combined heart-lung transplantation: an autopsy study. Hum Pathol. 1988;19:1403–16.
Yousem SA, Dauber JA, Keenan R, Paradis IL, Zeevi A, Griffith BP. Does histologic acute rejection in lung allografts predict the development of bronchiolitis obliterans? Transplantation. 1991;52:306–9.
Scott JP, Higenbottam TW, Sharples L, Clelland CA, Smyth RL, Stewart S. Wallwork risk factors for obliterative bronchiolitis in heart-lung transplant recipients. Transplantation. 1991;51:813–17.
Burke, C, Theodore J, Dawkins KD et al. Post-transplant obliterative bronchiolitis and other late lung sequelae in human heart-lung transplantation. Chest. 1986;6:824–9.
Yousem SA. Can transbronchial biopsy aid in the diagnosis of bronchiolitis obliterans in lung transplant recipients? Transplantation. 1994;57:151–3.
Cooper JD, Billingham M, Egan T et al. A working formulation for the standardization of nomenclature and for clinical staging of chronic dysfunction in lung allografts. J Heart Lung Transplant. 1993;12:713–16.
Zenati M, Dowling RD, Dummer JS et al. Influence of the donor lung on development of early infections in lung transplant recipients. J Heart Transplant. 1990;9:502–9.
Shankar S, Fulsham L, Read RC et al. Mucociliary function after lung transplantation. Transplant Proc. 1991;23:1222–3.
Herve P, Silbert D, Cerrina J et al. Impairment of bronchial mucociliary clearance in long-term survivors of heart/lung and double-lung transplantation. Chest. 1993;103:59–63.
Snell GI, de Hoyas A, Kjajden M et al. Pseudomonas cepacia in lung transplant recipients with cystic fibrosis. Chest. 1993;103:466–71.
Lewiston N, King V, Umetsu D et al. Cystic fibrosis patients who have undergone heart-lung transplantation benefit from maxillary sinus antrostomy and repeated sinus lavage. Transplant Proc. 1991;23:1207–8.
Dennis C, Caine N, Sharples L et al. Heart-lung transplantation for end-stage respiratory disease in patients with cystic fibrosis at Papworth Hospital. J Heart Lung Transplant. 1993;12:893–902.
Paradis IL, Duncan SR, Dauber JH, Yousem SA, Hardesty R, Griffith B. Distinguishing between infection, rejection, and the adult respiratory distress syndrome after human lung transplantation. J Heart Lung Transplant. 1992;11:S232–6.
de Hoyos AL, Patterson GA, Maurer JR et al. Pulmonary transplantation: early and late results. J Thorac Cardiovasc Surg. 1992;103:295–306.
Kramer MR, Marshall SE, Starnes VA, Gamberg P, Amitai Z, Theodore J. Infectious complications in heart-lung transplantation: analysis of 200 episodes. Arch Intern Med. 1993;153:2010–16.
Paradis IL, Williams P. Infection after lung transplantation. Sem Respir Infect. 1993;8:207–15.
McCabe RE. Diagnosis of pulmonary infections in immunocompromised patients. Med Clin N Am. 1988;72:1067–89.
Dauber JH, Paradis IL, Dummer JS. Infectious complications in pulmonary allograft recipients. Clin Chest Med. 1990;11:291–308.
Patterson TF, Androle VT, Zervos MJ, Therasse D, Kauffman CA. The epidemiology of pseudallescheriasis complicating transplantation: nosocomial and community-acquired infection. Mycoses. 1990;33:297–302.
Duncan SR, Dummer JS, Paradis IL et al. Cytomegalovirus infection and survival in pulmonary transplant recipients. J Heart Lung Transplant. 1991;10:638–46.
Maurer J, Tullis E, Scavuzzo M et al. Cytomegalovirus infection in isolated lung transplant recipients. J Heart Lung Transplant. 1991;10:647–9.
Smyth RL, Scott JP, Borysiewizc LK et al. Cytomegalovirus infection in heart-lung transplant recipients. Risk factors, clinical associations, and response to treatment. J Infect Dis. 1991;166:1045–50.
Nakhleh RE, Bolman RM, Henke CA, Hertz MI. Lung transplant pathology. A comparative study of pulmonary acute rejection and cytomegalovirus infection. Am J Surg Pathol. 1991;15:1197–201.
Fend F, Prior C, Margreiter R, Mikuz G. Cytomegalovirus pneumonitis in heart-lung transplant recipients: histopathology and clinicopathologic considerations. Hum Pathol. 1990;21:918–26.
Tazelaar HD. Perivascular inflammation in pulmonary infections: implications for the diagnosis of lung rejection. J Heart Lung Transplant. 1991;10:437–41.
Keenan RH, Lega ME, Dummer JS et al. Cytomegalovirus serologic status and post-operative infection correlated with risk of developing chronic rejection after pulmonary transplantation. Transplantation. 1991;51:433–8.
Smyth RL, Higenbottam TW, Scott JP et al. Herpes simplex virus infection in heart-lung transplant recipients. Transplantation. 1990;49:735–9.
Nash G. Necrotizing tracheobronchitis and bronchopneumonia consistent with herpetic infection. Hum Pathol. 1972;3:283.
Ramsey PG, Fike KH, Hackman RC et al. Herpes simplex virus pneumonia: clinical, virologic, and pathologic features in 20 patients. Ann Intern Med. 1982;97:813.
Hruban RH, Ren H, Kuhlman JE et al. Inflation-fixed lung: pathologic-radiologic (CT) correlation on lung transplantation. J Comp Tomogr. 1990;14:329–35.
Ohori NP, Michaels MG, Jaffe R, Williams P, Yousem SA. Adenovirus pneumonia in lung transplant recipients. Hum Pathol. 1995;26:1073–9.
Gyrzan S, Paradis IL, Zeevi A et al. Unexpected high incidence of Pneumocystis carinii infection in heart-lung transplantation. Am Rev Respir Dis. 1988;137:1268–74.
Dummer JS. Pneumocystis carinii infections in transplant recipients. Semin Respir Infect. 1990;1:50–7.
Hughes WT, Rivera GK, Schell MJ, Thornton D, Lott L. Successful intermittent chemoprophylaxis of Pneumocystis carinii pneumonitis N Engl J Med. 1987;317:1627–32.
Kramer MR, Stroehr C, Lewiston NJ, Starnes VA, Theodore J. Trimthoprim-sulfamethoxazole prophylaxis for Pneumocystis carinii infection in lung transplantation: how effective and for how long. Transplantation. 1992;53:586–9.
Nalesnik MA, Jaffe R, Starzl TE et al. The pathology of post-transplant lymphopro-liferative disorders occurring in the setting of cyclosporin A-prednisone immuno-suppression. Am J Pathol. 1988;133:173–92.
Yousem SA, Randhawa P, Locker J et al. Post-transplant lymphoproliferative disorders in heart-lung transplant recipients: primary presentation in the allograft. Hum Pathol. 1989;20:361–9.
Randhawa PS, Yousem SA, Paradis IL, Dauber JA, Griffith BP, Locker J. The clinical spectrum, pathology, and clonal analysis of Epstein-Barr virus-associated lymphoproliferative disorders in heart-lung transplant recipients. Am J Clin Pathol. 1989;92:177–85.
Rosendale B, Yousem SA. Discrimination of EBV related post transplant lymphoproliferations from acute rejection in lung allograft recipients. Arch Pathol Lab Med. 1995;119:418–23.
Hoffmann DG, Gedebou M, Jimenez A, Nichols WS, Marchevsky A. Detection of Epstein-Barr virus by polymerase chain reaction in transbronchial biopsies of lung transplant recipients: evidence of infection? Mod Pathol. 1993;6:555.
Stewart S. Pathology of lung transplantation. Sem Diag Pathol. 1992;9:210–13.
Johnson BA, Duncan DR, Ohori NP et al. Recurrence of sarcoidosis in pulmonary allograft recipients. Am Rev Respir Dis. 1993;148:1373–7.
Nine JS, Yousem SA. Lymphangiolciomyomatosis: recurrence after lung transplantation. J Heart Lung Transplant. 1994;13:714–19.
Baz MA, Russin PS, Van Trigt P, Davis RD, Roggli VL, Tapson VF. Recurrence of diffuse panbronchiolitis after lung transplantation. Am J Respir Crit Care Med. 1995;151:895–8.
Frost AE, Keller CA, Brown RW et al. Giant cell interstitial pneumonitis: disease recurrence in the transplanted lung. Am Rev Respir Dis. 1993;148:1401–4.
Barberis M, Harari S, Tironi A, Lampertico P. Recurrence of primary disease in a single lung transplant recipient. Transplant Proc. 1992;24:2660–2.
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1996 Kluwer Academic Publishers
About this chapter
Cite this chapter
Ohori, N.R., Yousem, S.A. (1996). Histopathology of Lung Transplantation. In: Cooper, D.K.C., Miller, L.W., Patterson, G.A. (eds) The Transplantation and Replacement of Thoracic Organs. Springer, Dordrecht. https://doi.org/10.1007/978-0-585-34287-0_55
Download citation
DOI: https://doi.org/10.1007/978-0-585-34287-0_55
Publisher Name: Springer, Dordrecht
Print ISBN: 978-0-7923-8898-2
Online ISBN: 978-0-585-34287-0
eBook Packages: Springer Book Archive